A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations

Rigshospitalet (Copenhagen University Hospital) - Finsencentret - Onkologisk Klinik, Copenhagen

NYU Langone Cancer Center, New York

Veterans General Hospital - Taipei, Taipei

Fox Chase Cancer Center, Philadelphia

START (Fundacion Jimenez Diaz), Madrid

Mayo Clinic Florida, Jacksonville

Sarah Cannon Research Institute - Lake Nona, Orlando

Sarah Cannon Research Institute, Nashville

START Midwest, Grand Rapids

University of Wisconsin Carbone Cancer Center, Madison

Mayo Clinic Rochester, Rochester

MD Anderson Cancer Center, Houston

National Taiwan University Hospital, Taipei

Kaohsiung Medical University Hospital, Kaohsiung City

Mayo Clinic Arizona, Phoenix

UC San Diego Moores Cancer Center, La Jolla

Beijing Cancer Hospital, Beijing

Massachusetts General Hospital, Boston

Seoul National University Hospital (SNUH), Seoul

Severance Hospital Yonsei University Health System, Seoul

Samsung Medical Center, Seoul